The dark side of paclitaxel
The bark extract of Pacific Yew (Taxus brevifolia) was first reported to have anti-tumor activity in 1963. The active constituent responsible for this activity was later identified in 1971 as paclitaxel [1]. Paclitaxel is a cytotoxic drug used in the treatment of variety of tumors including ovarian,...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | ספר |
| יצא לאור: |
Frontiers Media S.A.,
2011-12-01T00:00:00Z.
|
| נושאים: | |
| גישה מקוונת: | Connect to this object online. |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
| סיכום: | The bark extract of Pacific Yew (Taxus brevifolia) was first reported to have anti-tumor activity in 1963. The active constituent responsible for this activity was later identified in 1971 as paclitaxel [1]. Paclitaxel is a cytotoxic drug used in the treatment of variety of tumors including ovarian, breast, and non-small-cell lung cancers... |
|---|---|
| תאור פריט: | 10.4081/oncol.2010.71 1970-5557 1970-5565 |